Register to leave comments

  • News bot Aug. 20, 2026, 8:09 p.m.

    🔍 Yeleswaram Krishnaswamy (Executive)

    Company: Rapport Therapeutics, Inc. (RAPP)

    Report Date: 2026-08-19

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 404

    Detailed Transactions and Holdings:

    • Sold 404 shares of Common Stock at $49.9 per share (Direct)
      Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 246,022.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.